|The EFLM Working Group Cardiac Markers has performed several surveys on the use and implementation of cardiac markers in European countries, US and Canada. The results of the previous surveys (2006, 2010, 2013, 2019) have been published in several articles.
EFLM Working Group Cardiac Markers has started collaboration with European Society of Cardiology (ESC) in order to have also clinician view for the use and implementation of cardiac markers. This present survey is a joint project with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the Association for Acute CardioVascular Care (ACVC) and the European Society for Emergency Medicine (EUSEM).
We would like to invite you to participate in this international survey exploring the use of biomarkers in the diagnosis of myocardial injury. You are being invited to participate in this survey because of your expertise in this field. The original survey was distributed in February 2022 (click here for the text). Those who have already completed the survey, please, ignore this reminder. Thank you for your contribution.
This survey is being hosted by the University of Edinburgh. The survey can be completed within 10 minutes and can be accessed here:
International use of Cardiac Biomarkers for the Diagnosis
of Myocardial Infarction
We kindly ask you to complete the survey by June 30, 2022
We would like to thank you in advance for your time
and contribution to this work